Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Debarbieux, Laurent" or (type exact bookEditor and editor="Debarbieux, Laurent")

Mark
- misc
A bacteriophage journey at the European Medicines Agency

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili (UGent) , Isabelle Huys, Olivier Patey, Dirk Schoonjans, Mario Vaneechoutte (UGent) , Martin Zizi, et al.

(2016) FEMS MICROBIOLOGY LETTERS. 363(2).
Mark
- misc
- open access
A bacteriophage journey at the European Medicines Agency

Laurent Debarbieux, Jean-Paul Pirnay, Gilbert Verbeken, Daniel De Vos, Maia Merabishvili (UGent) , Isabelle Huys, Olivier Patey, Dirk Schoonjans, Mario Vaneechoutte (UGent) , Martin Zizi, et al.

(2016) FEMS MICROBIOLOGY LETTERS. 363(2).
Mark
- journalArticle
- open access
Quality and Safety Requirements for Sustainable Phage Therapy Products

Jean-Paul Pirnay, Bob G. Blasdel, Laurent Bretaudeau, Angus Buckling, Nina Chanishvili, Jason R. Clark, Sofia Corte-Real, Laurent Debarbieux, Alain Dublanchet, Daniel De Vos, et al.

(2015) PHARMACEUTICAL RESEARCH. 32(7). p.2173-2179
Mark
Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting

Isabelle Huys, Mario Vaneechoutte (UGent) , Gilbert Verbeken (UGent) and Laurent Debarbieux

(2013) RESEARCH IN MICROBIOLOGY. 164(7). p.806-810
Mark
Meeting report of the European Molecular Biology Organization (EMBO) symposium 'Viruses of microbes II', Brussels, July 2012

Pieter-Jan Ceyssens, Abram Aertsen, David M Donovan, Rob Lavigne, Matthew B Sullivan, Laurent Debarbieux and Mario Vaneechoutte (UGent)

(2013) RESEARCH IN MICROBIOLOGY. 164(7). p.799-805
Mark
- misc
The phage therapy paradigm: prêt-à-porter or sur-mesure?

Jean-Paul Pirnay, Daniel De Vos, Gilbert Verbeken (UGent) , Maia Merabishvili (UGent) , Nina Chanishvili, Mario Vaneechoutte (UGent) , Martin Zizi, Geert Laire, Rob Lavigne, Isabelle Huys, et al.

(2011) PHARMACEUTICAL RESEARCH. 28(4). p.934-937

Academic Bibliography

A bacteriophage journey at the European Medicines Agency

A bacteriophage journey at the European Medicines Agency

Quality and Safety Requirements for Sustainable Phage Therapy Products

Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting

Meeting report of the European Molecular Biology Organization (EMBO) symposium 'Viruses of microbes II', Brussels, July 2012

The phage therapy paradigm: prêt-à-porter or sur-mesure?

Contents

Support

Contact